摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-[(4-methylphenyl)thio]piperidine monohydrochloride | 101768-81-4

中文名称
——
中文别名
——
英文名称
4-[(4-methylphenyl)thio]piperidine monohydrochloride
英文别名
4-[(4-Methylphenyl)sulfanyl]piperidine hydrochloride;4-(4-methylphenyl)sulfanylpiperidine;hydrochloride
4-[(4-methylphenyl)thio]piperidine monohydrochloride化学式
CAS
101768-81-4
化学式
C12H17NS*ClH
mdl
——
分子量
243.801
InChiKey
AZEHGEQYOAWBMX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.26
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    37.3
  • 氢给体数:
    2
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    4-[(4-methylphenyl)thio]-1-phenylsulfonylpiperidine 、 苯酚sodium hydroxide氢溴酸 作用下, 生成 4-[(4-methylphenyl)thio]piperidine monohydrochloride
    参考文献:
    名称:
    N-(amino)alkyl)-1-pyrrolidine, 1-piperidine and
    摘要:
    新型吡咯烷、哌啶和高哌啶羧酰胺及硫代羧酰胺化合物,具有如下通式:##STR1## 其中X为--S--、--S(O)--或--S(O)2--;A为低级烷撑链,当p和d为一时,A1和A2为烷撑链;R、R1和R2为氢、低级烷基、苯基、环烷基或苯基烷基,且R1和R2可与相邻的氮原子形成杂环残基;Q为选定的芳香基团,并公开了作为心脏抗心律失常剂的药用可接受的酸加成盐。还公开了在吡咯烷、哌啶和高哌啶氮上未取代但带有--(A2)p--X--(A2)d--Q侧链的新型化学中间体。
    公开号:
    US04642348A1
点击查看最新优质反应信息

文献信息

  • N-[(amino)alkyl]-1-pyrrolidine, 1-piperidine and
    申请人:A. H. Robins Company, Inc.
    公开号:US04593102A1
    公开(公告)日:1986-06-03
    Novel pyrrolidine, piperidine and homopiperidinecarboxamide and thiocarboxamide compounds having the formula: ##STR1## wherein X is --S--, --S(O)-- or --S(O).sub.2 --; A is a loweralkalene chain and A.sup.1 and A.sup.2 are alkalene chains when p and d are one; R, R.sup.1 and R.sup.2 are hydrogen, loweralkyl, phenyl cycloalkyl or phenylalkyl and R.sup.1 and R.sup.2 may form a heterocyclic residue with the adjacent nitrogen atom; Q is a selected aromatic radical, and the pharmaceutically acceptable acid addition salts useful as cardiac antiarrhythmia agents are disclosed. Novel chemical intermediates, unsubstituted on pyrrolidine, piperidine and homopiperidine nitrogen but with --(A.sup.2).sub.p --X--(A.sup.2).sub.d --Q side chain are also disclosed.
    新型吡咯烷、哌啶和高哌啶羧酰胺及硫代羧酰胺化合物,具有如下通式:##STR1## 其中X为--S--、--S(O)--或--S(O)2--;A为低级烷撑链,当p和d为1时,A1和A2为烷撑链;R、R1和R2为氢、低级烷基、苯基、环烷基或苯基烷基,且R1和R2可与相邻的氮原子形成杂环残基;Q为选定的芳香基团,以及作为心脏抗心律失常药物使用的药用可接受酸加成盐被公开。还公开了在吡咯烷、哌啶和高哌啶氮原子上未取代,但具有--(A2)p--X--(A2)d--Q侧链的新型化学中间体。
  • N-[(Amino)Alkyl]-1-pyrrolidine, 1-piperidine and 1-homopiperidinecarboxamides (and thiocarboxamides) with sulphur linked substitution in the 2, 3 or 4-position
    申请人:A.H. ROBINS COMPANY, INCORPORATED
    公开号:EP0160436A2
    公开(公告)日:1985-11-06
    Pyrrolidine, piperidine and homopiperidine- carboxamide and thiocarboxamide compounds of the formula: wherein X is -S-, -S(0)- or -S(0)2-; A is a loweralkalene chain and A1 and A2 are alkalene chains when p and d are one; R, R1 and R2 are hydrogen, loweralkyl, phenyl cycloalkyl or phenylalkyl and R1 and R2 may form a heterocyclic residue with the adjacent nitrogen atom; Q is a selected aromatic radical, and the pharmaceutically acceptable acid addition salts are useful as cardiac antiarrhythmia agents. Chemical intermediates, unsubstituted on pyrrolidine, piperidine and homopiperidine nitrogen but with the -(A2)p-X-(A2)d-Q side chain are also disclosed.
    式中的吡咯烷、哌啶和均哌啶-羧酰胺和硫代羧酰胺化合物: 其中,X 是-S-、-S(0)- 或-S(0)2-;A 是低级烯烃链,当 p 和 d 为 1 时,A1 和 A2 是烯烃链;R、R1 和 R2 是氢、低级烷基、苯基环烷基或苯基烷基,R1 和 R2 可与相邻的氮原子形成杂环残基;Q 是选定的芳香基,药学上可接受的酸加成盐可用作抗心律失常剂。 还公开了吡咯烷、哌啶和高哌啶氮上未取代但具有-(A2)p-X-(A2)d-Q 侧链的化学中间体。
  • US4593102A
    申请人:——
    公开号:US4593102A
    公开(公告)日:1986-06-03
  • US4642348A
    申请人:——
    公开号:US4642348A
    公开(公告)日:1987-02-10
  • N-(amino)alkyl)-1-pyrrolidine, 1-piperidine and
    申请人:A. H. Robins Company, Incorporated
    公开号:US04642348A1
    公开(公告)日:1987-02-10
    Novel pyrrolidine, piperidine and homopiperidinecarboxamide and thiocarboxamide compounds having the formula: ##STR1## wherein X is --S--, --S(O)-- or --S(O).sub.2 --; A is a loweralkalene chain and A.sup.1 and A.sup.2 are alkalene chains when p and d are one; R, R.sup.1 and R.sup.2 are hydrogen, loweralkyl, phenyl cycloalkyl or phenylalkyl and R.sup.1 and R.sup.2 may form a heterocyclic residue with the adjacent nitrogen atom; Q is a selected aromatic radical, and the pharmaceutically acceptable acid addition salts useful as cardiac antiarrhythmia agents are disclosed. Novel chemical intermediates, unsubstituted on pyrrolidine, piperidine and homopiperidine nitrogen but with --(A.sup.2).sub.p --X--(A.sup.2).sub.d --Q side chain are also disclosed.
    新型吡咯烷、哌啶和高哌啶羧酰胺及硫代羧酰胺化合物,具有如下通式:##STR1## 其中X为--S--、--S(O)--或--S(O)2--;A为低级烷撑链,当p和d为一时,A1和A2为烷撑链;R、R1和R2为氢、低级烷基、苯基、环烷基或苯基烷基,且R1和R2可与相邻的氮原子形成杂环残基;Q为选定的芳香基团,并公开了作为心脏抗心律失常剂的药用可接受的酸加成盐。还公开了在吡咯烷、哌啶和高哌啶氮上未取代但带有--(A2)p--X--(A2)d--Q侧链的新型化学中间体。
查看更多